Chronic Myeloid Leukemia News and Research

RSS
Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. According to the American Cancer Society, CML is a type of cancer that starts in blood-forming cells of the bone marrow and then invades the blood. It can spread to the lymph nodes, spleen, liver, and other parts of the body. CML can also change into a fast-growing acute leukemia that invades almost any organ in the body.
ARIAD's ponatinib potently inhibits all four FGFRs abnormally expressed in multiple cancers

ARIAD's ponatinib potently inhibits all four FGFRs abnormally expressed in multiple cancers

Scientists identify new treatment target for squamous cell lung cancer

Scientists identify new treatment target for squamous cell lung cancer

Positive outcomes from imatinib trial in both older and younger patients with CML

Positive outcomes from imatinib trial in both older and younger patients with CML

PerkinElmer launches new oncology testing service for cancer patients

PerkinElmer launches new oncology testing service for cancer patients

Cephalon intends to make takeover bid for ChemGenex

Cephalon intends to make takeover bid for ChemGenex

Cancer drug Gleevec may hold promise against scleroderma: Study

Cancer drug Gleevec may hold promise against scleroderma: Study

MolecularMD and ARIAD collaborate to develop and commercialize CML, ALL diagnostic test

MolecularMD and ARIAD collaborate to develop and commercialize CML, ALL diagnostic test

KaloBios commences KB004 Phase 1 trial in patients with leukemia

KaloBios commences KB004 Phase 1 trial in patients with leukemia

Cellerant commences CLT-008 Phase I/II trial in patients with leukemia

Cellerant commences CLT-008 Phase I/II trial in patients with leukemia

Sarsia Seed provides follow-up funding for APIM Therapeutics

Sarsia Seed provides follow-up funding for APIM Therapeutics

CytRx reports $0.4M net income for 2010 vs. $4.8M net loss for 2009

CytRx reports $0.4M net income for 2010 vs. $4.8M net loss for 2009

Stemline's SL-401 receives FDA Orphan Drug designation for treatment of acute myeloid leukemia

Stemline's SL-401 receives FDA Orphan Drug designation for treatment of acute myeloid leukemia

New study finds liver instead of the brain as source of Alzheimer’s plaques

New study finds liver instead of the brain as source of Alzheimer’s plaques

Stemline licenses clinically active oncology vaccine for dual targeting of tumor bulk and cancer stem cells

Stemline licenses clinically active oncology vaccine for dual targeting of tumor bulk and cancer stem cells

Researchers identify cell of origin for sarcoma

Researchers identify cell of origin for sarcoma

CytRx's bafetinib helps reduce skeletal complications in cancer patients

CytRx's bafetinib helps reduce skeletal complications in cancer patients

Scientists reprogram marrow cells from patient with chronic myeloid leukemia

Scientists reprogram marrow cells from patient with chronic myeloid leukemia

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

FDA grants BioSante Orphan Drug designation for Melanoma Cancer Vaccine

FDA grants BioSante Orphan Drug designation for Melanoma Cancer Vaccine

MMRF, Synta collaborate for clinical development of ganetespib in multiple myeloma

MMRF, Synta collaborate for clinical development of ganetespib in multiple myeloma